LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 28.21 | 84.90 | 432 | 2091 | 0.2066 | 0.4219 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 28.21 | 84.90 | 1235 | 2091 | 0.5905 | 0.7846 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 28.21 | 84.90 | 69 | 2091 | 0.0330 | -0.0439 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 28.21 | 84.90 | 1077 | 2091 | 0.5149 | 0.7325 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 29.92 | 84.90 | 478 | 2237 | 0.2136 | 0.4421 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 29.92 | 84.90 | 1149 | 2237 | 0.5135 | 0.7366 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 29.92 | 84.90 | 48 | 2237 | 0.0215 | -0.1138 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 29.92 | 84.90 | 974 | 2237 | 0.4353 | 0.6769 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 31.62 | 84.90 | 567 | 2449 | 0.2315 | 0.4792 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 31.62 | 84.90 | 1273 | 2449 | 0.5197 | 0.7475 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 31.62 | 84.90 | 67 | 2449 | 0.0274 | -0.0476 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 31.62 | 84.90 | 1070 | 2449 | 0.4368 | 0.6861 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 33.32 | 84.90 | 593 | 2722 | 0.2178 | 0.4748 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 33.32 | 84.90 | 1193 | 2722 | 0.4382 | 0.6959 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 33.32 | 84.90 | 79 | 2722 | 0.0290 | -0.0143 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 33.32 | 84.90 | 1064 | 2722 | 0.3908 | 0.6576 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 35.03 | 84.90 | 652 | 2991 | 0.2180 | 0.4869 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 35.03 | 84.90 | 1234 | 2991 | 0.4125 | 0.6835 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 35.03 | 84.90 | 82 | 2991 | 0.0274 | -0.0067 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 35.03 | 84.90 | 1158 | 2991 | 0.3871 | 0.6628 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.73 | 84.90 | 891 | 3254 | 0.2738 | 0.5635 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.73 | 84.90 | 1346 | 3254 | 0.4136 | 0.6910 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.73 | 84.90 | 88 | 3254 | 0.0270 | 0.0068 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.73 | 84.90 | 1100 | 3254 | 0.3380 | 0.6274 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.43 | 84.90 | 1088 | 3459 | 0.3145 | 0.6110 | MN20160318_Q02 | G10 |